ArticleJournal of cancer research and clinical oncology2021

A 25-year retrospective, single center analysis of 343 WHO grade II/III glioma patients: implications for grading and temozolomide therapy.

Eike Steidl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.